Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ebola Outbreak 2014 - News, Updates and Related Investments -- Ignore unavailable to you. Want to Upgrade?

To: statesidereport who wrote (105)	8/7/2014 5:14:50 PM
From: Glenn Petersen	Read Replies (1) \| Respond to of 608

Tekmira Ebola drug gets regulator modification for possible human use Aug 7 (Reuters) - Tekmira Pharmaceutical Corp said on Thursday that the U.S. Food and Drug Administration had modified its clinical hold status on Tekmira's experimental Ebola treatment to enable its potential use in humans infected with the virus. The FDA told Burnaby, British Columbia-based Tekmira that it had modified the full clinical hold on the drug to a partial clinical hold, the company said in a statement. (Reporting by Rod Nickel in Winnipeg, Manitoba; Editing by Bernard Orr) finance.yahoo.com